Annual report pursuant to Section 13 and 15(d)

Supplemental Financial Information

v3.21.2
Supplemental Financial Information
12 Months Ended
Mar. 31, 2021
Quarterly Financial Information Disclosure [Abstract]  
Supplemental Financial Information

The following table presents the unaudited statements of operations data for each of the eight quarters in the period ended March 31, 2021. The information has been presented on the same basis as the audited financial statements and all necessary adjustments, consisting only of normal recurring adjustments, have been included in the amounts below to present fairly the unaudited quarterly results when read in conjunction with the audited financial statements and related notes. The operating results for any quarter should not be relied upon as necessarily indicative of results for any future period.

 

Quarterly Results of Operations (Unaudited)

 (in thousands, except share and per share amounts)

 

    Three Months Ended     Total  
   

June 30,

2020

   

September 30,

2020

   

December 31,

2020

   

March 31,

2021

   

Fiscal Year

2021

 
                               
Sublicense revenue   $ -     $ 334     $ 314     $ 442     $ 1,090  
Total revenue     -       334       314       442       1,090  
                                         
Operating expenses:                                        
 Research and development   $ 1,731     $ 2,358     $ 3,496     $ 4,891     $ 12,476  
 General and administrative     1,391       1,270       2,117       1,770       6,548  
  Total operating expenses     3,122       3,628       5,613       6,661       19,024  
Loss from operations     (3,122 )     (3,294 )     (5,299 )     (6,219 )     (17,934 )
                                         
Other income (expense), net:                                        
 Interest income (expense), net     (3 )     (4 )     1       8       2  
 Other income     1       -       -       -       1  
                                         
Loss before income taxes     (3,124 )     (3,298 )     (5,298 )     (6,211 )     (17,931 )
Income taxes     (3 )     -       -       -       (3 )
Net loss and comprehensive loss     (3,127 )     (3,298 )     (5,298 )     (6,211 )     (17,934 )
                                         
     Accrued dividend on Series B Preferred stock     (336 )     (347 )     (354 )     (349 )     (1,386 )
     Beneficial conversion feature on Series D                                        
        Preferred stock     -       -       -       (23,000 )     (23,000 )
                                         
     Net loss attributable to common stockholders   $ (3,463 )   $ (3,645 )   $ (5,652 )   $ (29,560 )   $ (42,320 )
                                         
Basic and diluted net loss per common share                                        
    attributable to common stockholders   $ (0.07 )   $ (0.05 )   $ (0.07 )   $ (0.20 )   $ (0.49 )
Weighted average shares used in computing                                        
 basic and diluted net loss per common share                                        
       attributable to common stockholders     51,321,355       67,082,935       81,086,105       145,966,502       86,133,644  

 

 

 

    Three Months Ended     Total  
   

June 30,

2019

   

September 30,

2019

   

December 31,

2019

   

March 31,

2020

   

Fiscal Year

2020

 
                               
Operating expenses:                              
 Research and development   $ 4,314     $ 4,205     $ 3,015     $ 1,840     $ 13,374  
 General and administrative     1,910       1,146       2,948       1,423       7,427  
  Total operating expenses     6,224       5,351       5,963       3,263       20,801  
Loss from operations     (6,224 )     (5,351 )     (5,963 )     (3,263 )     (20,801 )
                                         
Other expenses, net:                                        
 Interest income (expense), net     16       15       2       (3 )     30  
                                         
Loss before income taxes     (6,208 )     (5,336 )     (5,961 )     (3,266 )     (20,771 )
Income taxes     (2 )     -       -       (1 )     (3 )
Net loss and comprehensive loss     (6,210 )     (5,336 )     (5,961 )     (3,267 )     (20,774 )
                                         
     Accrued dividend on Series B Preferred stock     (302 )     (314 )     (322 )     (326 )     (1,264 )
     Net loss attributable to common stockholders   $ (6,512 )   $ (5,650 )   $ (6,283 )   $ (3,593 )   $ (22,038 )
                                         
Basic and diluted net loss per common share                                        
    attributable to common stockholders   $ (0.15 )   $ (0.13 )   $ (0.15 )   $ (0.08 )   $ (0.50 )
Weighted average shares used in computing                                        
 basic and diluted net loss per common share                                        
       attributable to common stockholders     42,622,965       42,622,965       43,158,889       47,094,781       43,869,523  

 

 

 

    Three Months Ended     Total  
   

June 30,

2019

   

September 30,

2019

   

December 31,

2019

   

March 31,

2020

   

Fiscal Year

2020

 
                               
Operating expenses:                              
 Research and development   $ 4,314     $ 4,205     $ 3,015     $ 1,840     $ 13,374  
 General and administrative     1,910       1,146       2,948       1,423       7,427  
  Total operating expenses     6,224       5,351       5,963       3,263       20,801  
Loss from operations     (6,224 )     (5,351 )     (5,963 )     (3,263 )     (20,801 )
                                         
Other expenses, net:                                        
 Interest income (expense), net     16       15       2       (3 )     30  
                                         
Loss before income taxes     (6,208 )     (5,336 )     (5,961 )     (3,266 )     (20,771 )
Income taxes     (2 )     -       -       (1 )     (3 )
Net loss and comprehensive loss     (6,210 )     (5,336 )     (5,961 )     (3,267 )     (20,774 )
                                         
     Accrued dividend on Series B Preferred stock     (302 )     (314 )     (322 )     (326 )     (1,264 )
     Net loss attributable to common stockholders   $ (6,512 )   $ (5,650 )   $ (6,283 )   $ (3,593 )   $ (22,038 )
                                         
Basic and diluted net loss per common share                                        
    attributable to common stockholders   $ (0.15 )   $ (0.13 )   $ (0.15 )   $ (0.08 )   $ (0.50 )
Weighted average shares used in computing                                        
 basic and diluted net loss per common share                                        
       attributable to common stockholders     42,622,965       42,622,965       43,158,889       47,094,781       43,869,523